In TAFRO syndrome, elevated levels of cytokines, including interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), are thought to induce inflammation and vascular permeability, leading to organ damage. This evidence concerns the gene IL6 and Castleman-Kojima disease.